Skip to content
Trial Eligibility
Menu

Ketorolac in Upper Extremity Tendinopathy and Arthropathy

NCT05292339

This study is recruiting at 4 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Osteoarthritis (OA) and inflammatory conditions of the tendons and joints of the shoulder, elbow, hand, and wrist are common yet disabling diseases. Standard management utilizes conservative measures to minimize pain and improve function. Conservative pharmacological management commonly includes corticosteroid and ketorolac injections which have been well investigated as a modality of pain control and improved function in large joint OA. However, fewer studies yielding mixed results on the duration of symptomatic relief exist for arthropathy and tendinopathy of these joints.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Osteoarthritis
  • Tendinopathy
  • Arthropathy

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Emory University
Last updated on ClinicalTrials.gov
September 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Georgia · 4

  • 12 Executive Park Drive · Atlanta, GA
  • Emory Saint Joseph's Hospital · Atlanta, GA
  • Emory University Orthopaedic and Spine Center · Atlanta, GA
  • Emory University Orthopaedic and Spine Hospital · Atlanta, GA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.